Bradykinesia in Parkinson's Disease
帕金森病的运动迟缓
基本信息
- 批准号:6710588
- 负责人:
- 金额:$ 28.5万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2002
- 资助国家:美国
- 起止时间:2002-03-15 至 2007-02-28
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION: (provided by applicant) One of the most debilitating aspects of
Parkinson?s disease is the inability to initiate and execute movements as
intended. The fundamental hypothesis behind the proposed research is that basal
ganglia impairments, as reflected in Parkinson?s disease, causes a disruption
in motor programming processes. It is postulated that there is increased noise
in the basal ganglia that produce abnormal timing, patterning, and
synchronization of discharges into the motor cortical areas. These
irregularities in turn reduce motor programming capabilities that are reflected
as alterations in the microstructure of a goal-oriented movement. We have
documented that Parkinson?s patients produce movements that exhibit shortened
primary submovement components, which then requires secondary, corrective
movements. Seven experiments are proposed which examine whether the altered
substructure of movements observed in PD is related to muscle activation
patterns, force-force variability relationships, and/or a reduced capability to
incorporate proprioceptive information at different stages of movement planning
and execution. The results of these experiments will be evaluated in
combination to allow us to determine which of these potential causes has the
greatest impact on primary submovement distance. The data obtained will be
useful in the basic science realm as well as the clinical setting; the former
by isolating the various motor deficits associated with PD, which may allow for
inferences to be made regarding structure-function relationships. In terms of
clinical relevance these results will assist in identifying where practitioner
interventions or outcome measures should be targeted.
描述:(由申请人提供)最使人衰弱的方面之一
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
GEORGE E. STELMACH其他文献
GEORGE E. STELMACH的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('GEORGE E. STELMACH', 18)}}的其他基金
MOVEMENT ORGANIZATION DYSFUNCTION IN PARKINSONS
帕金森病患者的运动组织功能障碍
- 批准号:
6937815 - 财政年份:2000
- 资助金额:
$ 28.5万 - 项目类别:
MOVEMENT ORGANIZATION DYSFUNCTION IN PARKINSONS
帕金森病患者的运动组织功能障碍
- 批准号:
6647754 - 财政年份:2000
- 资助金额:
$ 28.5万 - 项目类别:
MOVEMENT ORGANIZATION DYSFUNCTION IN PARKINSONS
帕金森病患者的运动组织功能障碍
- 批准号:
6394267 - 财政年份:2000
- 资助金额:
$ 28.5万 - 项目类别:
MOVEMENT ORGANIZATION DYSFUNCTION IN PARKINSONS
帕金森病患者的运动组织功能障碍
- 批准号:
6196374 - 财政年份:2000
- 资助金额:
$ 28.5万 - 项目类别:
MOVEMENT ORGANIZATION DYSFUNCTION IN PARKINSONS
帕金森病患者的运动组织功能障碍
- 批准号:
6529450 - 财政年份:2000
- 资助金额:
$ 28.5万 - 项目类别:
相似国自然基金
新型F-18标记香豆素衍生物PET探针的研制及靶向Alzheimer's Disease 斑块显像研究
- 批准号:81000622
- 批准年份:2010
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
阿尔茨海默病(Alzheimer's disease,AD)动物模型构建的分子机理研究
- 批准号:31060293
- 批准年份:2010
- 资助金额:26.0 万元
- 项目类别:地区科学基金项目
跨膜转运蛋白21(TMP21)对引起阿尔茨海默病(Alzheimer'S Disease)的γ分泌酶的作用研究
- 批准号:30960334
- 批准年份:2009
- 资助金额:22.0 万元
- 项目类别:地区科学基金项目
相似海外基金
Pathophysiological mechanisms of hypoperfusion in mouse models of Alzheimer?s disease and small vessel disease
阿尔茨海默病和小血管疾病小鼠模型低灌注的病理生理机制
- 批准号:
10657993 - 财政年份:2023
- 资助金额:
$ 28.5万 - 项目类别:
Social Connectedness and Communication in Parents with Huntington''s Disease and their Offspring: Associations with Psychological and Disease Progression
患有亨廷顿病的父母及其后代的社会联系和沟通:与心理和疾病进展的关联
- 批准号:
10381163 - 财政年份:2022
- 资助金额:
$ 28.5万 - 项目类别:
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease
更年期驱动的 DNA 损伤和表观遗传失调在阿尔茨海默病中的作用
- 批准号:
10531959 - 财政年份:2022
- 资助金额:
$ 28.5万 - 项目类别:
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease
更年期驱动的 DNA 损伤和表观遗传失调在阿尔茨海默病中的作用
- 批准号:
10700991 - 财政年份:2022
- 资助金额:
$ 28.5万 - 项目类别:
Interneurons as early drivers of Huntington´s disease progression
中间神经元是亨廷顿病进展的早期驱动因素
- 批准号:
10518582 - 财政年份:2022
- 资助金额:
$ 28.5万 - 项目类别:
Interneurons as Early Drivers of Huntington´s Disease Progression
中间神经元是亨廷顿病进展的早期驱动因素
- 批准号:
10672973 - 财政年份:2022
- 资助金额:
$ 28.5万 - 项目类别:
Social Connectedness and Communication in Parents with Huntington''s Disease and their Offspring: Associations with Psychological and Disease Progression
患有亨廷顿病的父母及其后代的社会联系和沟通:与心理和疾病进展的关联
- 批准号:
10585925 - 财政年份:2022
- 资助金额:
$ 28.5万 - 项目类别:
Oligodendrocyte heterogeneity in Alzheimer' s disease
阿尔茨海默病中的少突胶质细胞异质性
- 批准号:
10180000 - 财政年份:2021
- 资助金额:
$ 28.5万 - 项目类别:
Serum proteome analysis of Alzheimer´s disease in a population-based longitudinal cohort study - the AGES Reykjavik study
基于人群的纵向队列研究中阿尔茨海默病的血清蛋白质组分析 - AGES 雷克雅未克研究
- 批准号:
10049426 - 财政年份:2021
- 资助金额:
$ 28.5万 - 项目类别:
Repurposing drugs for Alzheimer´s disease using a reverse translational approach
使用逆翻译方法重新利用治疗阿尔茨海默病的药物
- 批准号:
10295809 - 财政年份:2021
- 资助金额:
$ 28.5万 - 项目类别:














{{item.name}}会员




